• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,708.52 -442.93
( -0.57%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Zenlabs Ethica Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
530697
INE546F01013
13.0721895
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
20.97
EPS(TTM)
Face Value()
Div & Yield %
0.03
10
0
 

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 1.81 crore in the March 2026 quarter
May 30,2026
Net Loss of Pharmaids Pharmaceuticals reported to Rs 1.81 crore in the quarter ended March 2026 as against net loss of Rs 3.94 crore during the previous quarter ended March 2025. Sales rose 50.52% to Rs 7.18 crore in the quarter ended March 2026 as against Rs 4.77 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 11.72 crore in the year ended March 2026 as against net loss of Rs 10.78 crore during the previous year ended March 2025. Sales rose 43.34% to Rs 27.88 crore in the year ended March 2026 as against Rs 19.45 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7.184.77 51 27.8819.45 43
OPM %-4.74-81.76 --48.53-65.55 -
PBDT-0.89-4.84 82 -16.74-14.74 -14
PBT-1.37-5.46 75 -18.76-17.18 -9
NP-1.81-3.94 54 -11.72-10.78 -9